Together we Drive the Future

Stem Cell Product Development & Commercialization

register 3 for the price of 2 with the coupon code rcdvb!

registration button

Stem Cell Summit

Stem Cell Research & Regenerative Medicine

Stem Cell Product Development & Commercialization

Dear Colleague,

We welcome you to GTCbio’s 6th Stem Cell Product Development & Commercialization Conference. This forum presents cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, funding, regulations, manufacturing, product development, and the business of stem cells. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be discussed. Come join us to learn what categories of companies are currently commercially viable, how they’re being funded, and what kind of strategic relationships are available within the industry!


Session Topics:

  1. Joint Plenary Session: Where do We Stand with Cell Therapy in Diabetes?
  2. Stem Cells for Drug Discovery & Disease Modeling
  3. Regulatory Challenges in Cell Therapy
  4. Manufacturing and Scalable Processes
  5. Commercialization: Creating Sustainable Business Models
  6. Funding and Partnering
  7. Biotech Showcase: Emerging Pipelines


This conference is part of the Stem Cell Summit taking place April 5-7, 2017 in Boston, MA which includes two back-to-back conferences:

April 5-6, 2017: 14th Stem Cell Research & Regenerative Medicine Conference
April 6-7, 2017: 6th Stem Cell Product Development & Commercialization Conference


Best regards,

The 2017 Advisory Committee


2017 Advisory Board Members
Stephen Chang, The New York Stem Cell Foundation
Douglas Losordo, Caladrius Biosciences
Robert Deans, BlueRock Therapeutics
Alain Vertes, GmbH
Daniel Anderson, Massachusetts Institute of Technology
Edward Lanphier, Sangamo Biosciences
Khalid Shah, Harvard Medical School; Massachusetts General Hospital
Yang (Ted) Teng, Harvard University & The Brigham and Women’s Hospital
James Ankrum, University of Iowa
Hardy T S Kagimoto, Healios K.K (RIKEN Venture)
Robert Halliwell, University of the Pacific
Devyn Smith, Pfizer
Jiwen Zhang, GE Healthcare
Anthony Ting, Athersys
Julie G. Allickson, Wake Forest Institute for Regenerative Medicine
Tiina Palomaki, Finnish Medicines Agency
Satish Medicetty , GTCbio